HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Enters Tooth Whitening Category With Rembrandt Purchase

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson has signed a definitive agreement to purchase the Rembrandt oral care brand from Procter & Gamble's Gillette division, a transaction that would provide the consumer products company entry into the tooth whitening segment, the firm announced

You may also be interested in...



J&J Acquires Listerine, Lubriderm As Part Of $16.6 Bil. Pfizer Deal

Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare augments the company's oral care division into a billion dollar-plus business and expands the segment's global reach, the company said

J&J Acquires Listerine, Lubriderm As Part Of $16.6 Bil. Pfizer Deal

Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare augments the company's oral care division into a billion dollar-plus business and expands the segment's global reach, the company said

Rembrandt divestiture

FTC is collecting public comments through Dec. 7 on the proposed divestiture of the Rembrandt toothpaste and tooth whitening business by Procter & Gamble and Gillette, commission says. Recently merged consumer products companies submitted a petition to FTC requesting the sale be approved. P&G and Gillette announced the proposed sale of the brand, a condition of FTC clearance of the merger, to Johnson & Johnson's Personal Products Company in October (1"The Rose Sheet" Oct. 31, 2005, p. 8)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013467

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel